Sopharma AD (BUL:SFA)
5.80
0.00 (0.00%)
At close: Feb 26, 2025
Sopharma AD Revenue
In the year 2024, Sopharma AD had annual revenue of 2.15B BGN with 13.62% growth. Sopharma AD had revenue of 593.58M in the quarter ending December 31, 2024, with 16.07% growth.
Revenue
2.15B
Revenue Growth
+13.13%
P/S Ratio
0.45
Revenue / Employee
398.79K
Employees
4,721
Market Cap
967.94M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.15B | 257.15M | 13.62% |
Dec 31, 2023 | 1.89B | 216.43M | 12.95% |
Dec 31, 2022 | 1.67B | 60.17M | 3.73% |
Dec 31, 2021 | 1.61B | 165.21M | 11.42% |
Dec 31, 2020 | 1.45B | 158.02M | 12.27% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shelly Group SE | 208.70M |
Tchaikapharma High Quality Medicines AD | 53.14M |
Speedy AD | 519.17M |
First Investment Bank AD | 418.43M |
Eurohold Bulgaria AD | 2.64B |
M+S Hydraulic AD | 145.20M |
Holding Varna AD | 88.88M |
Smart Organic AD | 93.58M |